Next report date
Report period
Q1 2024
EPS estimate
−0.43USD
Revenue estimate
—
−82.44 MUSD
38.13 M
Om Black Diamond Therapeutics, Inc.
Sektor
Bransch
VD
Mark A. Velleca
Webbplats
Huvudkvarter
Cambridge
Employees (FY)
54
Grundat
2014
FIGI
BBG00MS4Y0W9
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
